Effects of quercetin in preclinical models of Parkinson's disease: A systematic review

Documenti analoghi

• A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease
  di: Nabanita Ghosh, et al.
  Pubblicazione: (2024)
• Decreased blood pressure with acute administration of quercetin in L‐NAME‐induced hypertensive rats
  di: Siluleko A. Mkhize, et al.
  Pubblicazione: (2024)
• Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies
  di: Raimo K. Tuominen, et al.
  Pubblicazione: (2024)
• Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models
  di: Carlos Franciney Moreira Vasconcelos, et al.
  Pubblicazione: (2024)
• Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
  di: Maria de Fátima dos Santos Sampaio, et al.
  Pubblicazione: (2024)